The glioma tumor microenvironment (TME) further exacerbates NK cell suppression, as evidenced by the secretion of transforming growth factor-beta (TGFβ) by various cellular constituents, leading to downregulation of the NKG2D-activating receptor on NK cells isolated from GBM patients [134]. This evidence concerns the gene TGFB1 and neoplasm.